Our Poster Presentation:
Image
Trudell Medical International is a global leader in respiratory disease management. Every day we work with patients, caregivers, health care providers, and pharmaceutical partners to help patients breathe better so they can live fuller lives.
Image
Image
Can a Mixing Inlet Interposed Between a Pressurized Metered Dose Inhaler-Spacer Combination and Cascade Impactor Enable Effective Performance Testing at Widely Different Inhalation Flow Rates?
The primary purpose of our study was to discover whether a Miller MI used in conjunction with an NGI could be used to evaluate a pMDI with spacer add-on device at 30 L/min and at sampling flow rates comparable with those for the low flow MMI.
From our headquarters in Canada, we design and manufacture high-quality products sold in over 100 countries. Our devices include leading brands like the AEROCHAMBER Brand of spacers, the AEROCOUNT dose counter, the AEROBIKA* OPEP Device, and the AEROECLIPSE* Brand of breath actuated nebulizers, as well as a connected technology platform designed to enhance our standard devices and unlock greater value from care pathways. Our clinically proven, award-winning products are both patient-centric and science-backed, supported with 100+ peer reviewed articles in leading clinical journals.
We are proud to be the recipients of the Bronze EcoVadis Medal (2025) for sustainability management systems and operate a Quality Management System certified to ISO13485:2016, reflecting the principles through which we pursue our duty to patients and partners alike.
For more information, visit www.trudellmed.com/global/en/sustainability
Featured Products:
The AeroCount* Dose Counter
Trudell Medical International is your trusted partner in Dose Counter Technology and Aerosol Drug Delivery, offering two advanced dose counters to help patients manage their medication effectively.
The AeroChamber Plus* Flow-Vu* Spacer
The AeroChamber* brand of chambers is extensively validated for safety and efficacy through numerous third-party clinical evaluations across diverse patient populations and various MDIs. It is the most studied spacer brand, supported by hundreds of in-vitro and in-vivo studies and listed in prescribing instructions for most MDIs. Included in hundreds of peer-reviewed studies and product monographs of many pMDIs, it features the user-friendly Flow-Vu* indicator for proper use assurance. Its global availability ensures widespread access and its capacity to hold medication longer allows for more consistent delivery.
The AeroEclipse* BAN* Nebulizer
With breath actuated delivery, aerosol is only produced when you breathe in. This means medication is not wasted between breaths or if you need to take a break (for example if you need to cough or have a conversation). This puts you in control of your aerosol treatment. Other nebulizers continuously produce aerosol regardless of whether you are inhaling, exhaling or resting, resulting in medication being lost to the air instead of delivered to your lungs.